Uziq S 250mg/125mg Injection
Marketer
Dr Kumars Pharmaceuticals
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Uziq S 250mg/125mg Injection
Combiflox 250mg/125mg Injection is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby curbing infection spread. Administration must be under a physician's direct guidance. Consistent adherence to the prescribed schedule is crucial; completing the full course is vital, even with symptom improvement, as premature cessation might reduce efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects warrant immediate medical attention. Allergic reactions (rash, itching, edema, dyspnea) require prompt emergency care. Inform your doctor of all current medications before commencing treatment. Pregnant or lactating individuals should consult their physician prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and ample hydration are recommended for optimal recovery. Your physician may order blood tests and imaging to monitor treatment response.
Primary Ingredients of Uziq S 250mg/125mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Uziq S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Uziq S 250mg/125mg Injection:
Administering this medication will be done by your physician or their qualified staff; self-medication is strictly prohibited.
Common Side effects of Uziq S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Uziq S 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Uziq S 250mg/125mg Injection works:
Ceftriaxone/Sulbactam 250mg/125mg Injection (Uziq S) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Uziq S 250mg/125mg Injection.
PregnancySAFE IF PRESCRIBED
Administration of Uziq S 250mg/125mg Injection is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials remain scarce.
Breast feedingCAUTION
Administering Uziq S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Uziq S 250mg/125mg Injection can potentially reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Uziq S 250mg/125mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Exercise caution when administering Uziq S 250mg/125mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for Uziq S 250mg/125mg Injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Uziq S 250mg/125mg Injection :
Should you inadvertently omit a scheduled dose of Uziq S 250mg/125mg Injection, seek advice from your physician.
Facts to Know About Uziq S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently